DGRI News 0.0007 08/07/2014 04:55:03 Dutch Gold Resources (D

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Dutch Gold Resources (DGRI) 0.0007 $DGRI

US House Clears Cannibis Banking Bill, Dutch Gold to Upgrade Finance420.com Site
ACCESSWIRE - Tue Jul 22, 8:40AM CDT
ATLANTA, GA / ACCESSWIRE / July 22, 2014 / (http://dutchgoldinc.com) today announced that it has plans to upgrade www.Finance420.com in light of recent legislation passed by the US House of Representatives.

Dutch Gold Executes License Agreement with Abba Medix Corporation
ACCESSWIRE - Thu Jul 17, 6:00AM CDT
Canadian MMJ Company Acquires Exclusive Rights to Potency Test Kit and Hemp Flavored Teas in Canada

Dutch Gold Enters Bottled Beverage Market
ACCESSWIRE - Tue Jul 15, 8:36AM CDT
Dutch Gold Enters Bottled Beverage Market

Dutch Gold Acquires Technology for Potency Test Kit Marketing and Development Plans to Run Concurrently
ACCESSWIRE - Thu Jul 10, 7:00AM CDT
ATLANTA, GA / ACCESSWIRE / July 10 2014 / Dutch Gold Resources, Inc. (DGRI.OTC) (the "Company" (http://dutchgoldinc.com) today announced that its' subsidiary, Ascendant Analytics, Inc. (AAI), has acquired certain technology that will speed the development of its previously announced potency test kit for consumers.

Dutch Gold Makes Progress in Balance Sheet Improvement Subsidiary, Dutch Mining LLC, Files Chapter 7 Proceeding
ACCESSWIRE - Thu Jun 12, 8:31AM CDT
ATLANTA, GA / ACCESSWIRE / June 12, 14 / Dutch Gold Resources, Inc. (DGRI.OTC) (the "Company" (http://dutchgoldinc.com) today announced its' subsidiary, Dutch Mining LLC has filed for liquidation in the United States Bankruptcy Court in the Northern District of Georgia. There should no impact on the operations of Dutch Gold Resources, Inc., except that its' balance sheet should be much improved at the conclusion of the liquidation of the defunct subsidiary, to the extent of the debt extinguishment that is being sought.

Newly Formed Dutch Gold Subsidiary, Ascendant Analytics, Inc. to Launch Consumer Potency Testing Product
ACCESSWIRE - Wed Jun 04, 7:34AM CDT
ATLANTA, GA / ACCESSWIRE / June 4, 2014 / Dutch Gold Resources, Inc. (DGRI.OTC), an emerging financial services company serving the medical marijuana "MMJ" industry, today announced that it has formed a new subsidiary, Ascendant Analytics, Inc. (AAI) which will produce and market a consumer potency testing kit for MMJ. The company anticipates the kits being available to consumers by year end.

Dutch Gold Updates Crowd Funding Pipeline
ACCESSWIRE - Thu May 29, 8:15AM CDT
ATLANTA, GA / ACCESSWIRE / May 29, 2014 / Dutch Gold Resources, Inc. (DGRI.OTC) (the "Company" (http://dutchgoldinc.com) today announced that it has selected a third company to add to the launch of its new website http://www.mmjcrowdfund.com on June 20, 2014 and now has only two slots remaining for the initial launch.

Dutch Gold Announces the Launch of Crowd Funding Site to Solicit Companies that Seek Funding
ACCESSWIRE - Tue May 27, 8:30AM CDT
ATLANTA, GA / ACCESSWIRE / May 27, 2014 / Dutch Gold Resources, Inc. (DGRI.OTC) (the "Company" (http://dutchgoldinc.com) today announced that it will launch its crowd-funding portal for the MMJ sector. On June 20, 2014. The Company's technology team has completed the functionality of the site, http://www.mmjcrowdfund.com/ and is now three soliciting companies that are seeking capital.

Dutch Gold Updates Plan to Return to Full Reporting Status, Address Balance Sheet Issues, Address DTCC Matters
ACCESSWIRE - Tue Apr 01, 8:23AM CDT
ATLANTA, GA / ACCESSWIRE / April 1, 2014 / Dutch Gold Resources, Inc. (DGRI.OTC) (the "Company" (http://dutchgoldinc.com) today announced that it has begun the process to return to full reporting compliance with the Securities and Exchange Commission, and to address some of the debt load that has complicated the Company's ability to fund its' initiatives.

Peer-to-Peer Payments Technology for the Medical Marijuana Sector - Dutch Gold Adds to Portfolio of Alternative Merchant Services for MMJ Retailers
ACCESSWIRE - Fri Mar 28, 8:31AM CDT
ATLANTA, GA / ACCESSWIRE / March 28, 2014 / Dutch Gold Resources, Inc. (DGRI.OTC) (the "Company" (http://dutchgoldinc.com) today announced that it has begun development of a proprietary Peer to Peer (P2P) Payments technology specifically for the MMJ sector.

Point of Banking Solution for the Medical Marijuana Sector Dutch Gold Offers Alternative Merchant Service for MMJ Retailers
ACCESSWIRE - Thu Mar 20, 8:36AM CDT
Atlanta, GA / http://www.myprgenie.com/ via ACCESSWIRE / March 20, 2014 / Dutch Gold Resources, Inc. (DGRI.OTC) (the "Company" today announced that it has entered into an agreement to immediately begin to offer a Point of Banking solution to MMJ merchants as an alternative to traditional merchant account services and to facilitate secure merchant transactions.

Medical Marijuana Sector Services To Be Provided by Dutch Gold Company to Provide Specialized Financial and Business Services
ACCESSWIRE - Thu Mar 13, 6:54PM CDT
Atlanta, GA / http://www.myprgenie.com/ via ACCESSWIRE / March 13, 2014 / Dutch Gold Resources, Inc. (DGRI.OTC) (the "Company" (www.dutchgoldinc.com) today announced that it has entered the financial and business services industry with a special focus on the medical marijuana sector. Shareholders and other interested parties are requested to request additional information by emailing info@DutchGoldInc.com.

FBC Holding announces another Executed LOI with Dutch Gold Resources, Inc.
PR Newswire - Tue May 07, 7:00AM CDT
(OTCQB: FBCD) FBC Holding, Inc. would like to update its shareholders on recent events.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 183

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Moon Base Ambitions: Impulse Space Wins Key NASA Contracts

Updated Category News Views 742

NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 235

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 63

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 437

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 209

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 256

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 222

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 490

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 221

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading

Top 5 Most Recently Viewed Articles

Marina Genova Joins SEA Index to Promote Sustainable Yachting

Updated Category News Views 173

Marina Genova Enters SEA Index as an Institutional Member Recently, the Superyacht Eco Association – SEA Index welcomed Marina Genova, a prominent destination for yachting in the Mediterranean, as an Institutional Member. This collaboration signifies a crucial step in the yachting community's commitment to integrating environmental sustainability into its operations....

Continue Reading
Warren Buffett’s Top 2025 Stock Picks You Need to Know

Updated Category News Views 2610

Warren Buffett’s Strategic Stock Investments for 2025 Warren Buffett, the Oracle of Omaha, is known for his keen investment strategies and ability to recognize value in both good and bad market conditions. In the current volatile landscape, his portfolio continues to evolve, with some old favorites and new bets that show his forward-thinking approach. As we look ahead...

Continue Reading
Graves' Ophthalmopathy Market Surges with New Therapies

Updated Category News Views 50

Unexpected Growth in Graves' Ophthalmopathy Market Over the next decade, we're seeing the Graves' ophthalmopathy market gearing up for some serious growth, clocking in at a hefty compound annual growth rate of 9%. A good chunk of this is thanks to Viridian's newest player, LUMVOA, getting the green light, sending competitors scrambling and pushing innovation into...

Continue Reading
Tris Pharma Launches ONYDA XR: A New ADHD Liquid Solution

Updated Category News Views 210

So back in 2024, Tris Pharma rolled out ONYDA™ XR—this liquid medication aimed at tackling ADHD in kids six and older. It was billed as a game changer, especially since the FDA gave it the green light. The desks were buzzing about this first-of-its-kind non-stimulant therapy, positioning it like a golden ticket for parents tired of conventional stimulants that might...

Continue Reading
JPMorgan Updates Price Target for W. P. Carey to $70

Updated Category News Views 242

JPMorgan Boosts W. P. Carey's Price Target Recently, JPMorgan has refreshed its price target for W. P. Carey & Co. (NYSE: WPC), raising it from $68.00 to $70.00, while retaining an Overweight rating on the stock. This adjustment comes ahead of the company’s third-quarter earnings announcement, indicating the firm's confidence in W. P. Carey’s future potential....

Continue Reading